New Zealand vs Tonga: New cases tested for RR-/MDR-TB

New Zealand
100.0%
in 2014
Tonga
100.0%
in 2023
New Zealand rank
1st
Tonga rank
1st

New cases tested for RR-/MDR-TB over time

  • New Zealand
  • Tonga
020406080100200520142023

How they compare

New Zealand currently reports 100.0% against 100.0% in Tonga, a difference of 0.0%.

Across all 5 years both countries report, New Zealand has been ahead every year.

New Zealand ranks 1st and Tonga ranks 1st of 192 countries.

New Zealand has averaged higher in every one of the 1 decades both report.

Frequently asked questions

Which has higher new cases tested for rr-/mdr-tb, New Zealand or Tonga?
New Zealand, at 100.0% against 100.0% in Tonga as of 2014.
What is the difference in new cases tested for rr-/mdr-tb between New Zealand and Tonga?
0.0%, with New Zealand ahead.
How many years of comparable data are there for New Zealand and Tonga?
5 years are reported by both, from 2010 to 2014.
How do New Zealand and Tonga rank globally for new cases tested for rr-/mdr-tb?
New Zealand ranks 1st and Tonga ranks 1st of 192 countries.
Where does this data come from?
World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

New Zealand vs Tonga: New cases tested for RR-/MDR-TB. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 10 September 2026, from https://health.statizoid.com/compare/new-cases-tested-for-rr-mdr-tb-percent/new-zealand/tonga/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/compare/new-cases-tested-for-rr-mdr-tb-percent/new-zealand/tonga/">New Zealand vs Tonga: New cases tested for RR-/MDR-TB</a> — Statizoid

About this data

Indicator
New cases tested for RR-/MDR-TB (%)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
205 places, 3,388 data points, 2005–2024
Last refreshed